Carboplatin’s effectiveness stems from the ability of CBDCA to act as a good leaving group to enable binding of the platinum complex to bind to DNA.5 This change from chloride groups to the CBDCA, has tweaked the mechanism and properties of carboplatin from cisplatin. These exact mechanistic changes are still being researched.
Carboplatin has a relatively similar mechanism to cisplatin except it has a slower rate of aquation/activated due to the slower substitution of the bidentate cyclobutane dicarboxylate ligand with water.4 The similarity of the mechanism is due to the similarities in the structures of carboplatin and cisplatin.
Platinum-based drugs all form platinum-DNA adducts with DNA. After the leaving groups leave (cyclobutane-1,1-dicarboxylate for carboplatin) during aquation, the two ammine groups remain on the platinum.